Viking Therapeutics (VKTX) Financials

The income statement of Viking Therapeutics Inc (VKTX) provides a detailed overview of the company's financial performance. It includes information about the revenue generated, expenses incurred, and the net income from stockholders. The gross profit represents the difference between the total revenue and the cost of goods sold. Viking Therapeutics Inc (VKTX) has been able to maintain a steady growth in its total revenue over the years.

The balance sheet of Viking Therapeutics Inc (VKTX) shows the company's financial position at a specific point in time. It includes information about the company's total assets, total liabilities, and stockholders' equity. The cash equivalents represent the short-term investments that can be easily converted into cash. Viking Therapeutics Inc (VKTX) has a favorable stockholders' equity, indicating a strong financial position.

Viking Therapeutics Inc (VKTX) has managed its debt efficiently, as indicated by its net debt. The total debt represents the amount of money that the company owes to creditors. Viking Therapeutics Inc (VKTX) has a lower total debt compared to its total assets, which is a positive sign. The company's total liabilities, including both short-term and long-term obligations, are also within a manageable range.

The cash flow statement of Viking Therapeutics Inc (VKTX) provides information about the company's cash inflows and outflows during a specific period. It includes information about the operating cash flow, investing cash flow, and financing cash flow. The operating cash flow represents the cash generated from the company's core operations. Viking Therapeutics Inc (VKTX) has shown consistent positive operating cash flow, indicating a healthy business operation.

The investing cash flow represents the cash used for investments, such as purchasing property, plant, and equipment. Viking Therapeutics Inc (VKTX) has made strategic investments to support its growth and development. The financing cash flow includes activities related to raising capital, such as issuing shares or borrowing money. Viking Therapeutics Inc (VKTX) has effectively managed its financing activities to support its business expansion.

Lastly, the free cash flow represents the cash left over after deducting the capital expenditures from the operating cash flow. Viking Therapeutics Inc (VKTX) has generated a positive free cash flow, indicating its ability to invest in growth opportunities without relying heavily on external financing. Overall, the financials of Viking Therapeutics Inc (VKTX) reflect a strong and well-managed company.